4//SEC Filing
Madan Ajay 4
Accession 0001209191-21-016278
CIK 0001658247other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 5:25 PM ET
Size
5.5 KB
Accession
0001209191-21-016278
Insider Transaction Report
Form 4
Madan Ajay
Chief Development Officer
Transactions
- Award
Stock Option (right to buy)
2021-02-26+131,000→ 131,000 totalExercise: $15.29Exp: 2031-02-25→ Common Stock (131,000 underlying)
Footnotes (1)
- [F1]The stock option shall vest and become exercisable in a series of forty-eight (48) successive equal monthly installments measured from the vesting commencement date of February 26, 2021.
Documents
Issuer
Crinetics Pharmaceuticals, Inc.
CIK 0001658247
Entity typeother
Related Parties
1- filerCIK 0001807856
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 5:25 PM ET
- Size
- 5.5 KB